24/7 Patient Assistance: 760-405-8205
Hospitals & Clinics
specialties & services
Dr. Kathy Pan graduated the medical school from the University of California San Diego School of Medicine and completed both her residency and fellowship program at the Harbor- UCLA Medical Center. She is specialized in Medical Oncology and board certified in Internal Medicine. Dr. Pan has been in practice for more than 3 years and is affiliated with the Harbor-UCLA Medical Center. She has also contributed to three research publications.
University of California San Diego School of Medicine
Medical School
Harbor - UCLA Medical Center
Residency
Harbor - UCLA Medical Center
Fellowship
American Board of Internal Medicine
Benefit/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race/ethnicity.
Chlebowski RT, Haque R, Hedlin H, Col N, Paskett E, Manson JE, Kubo JT, Johnson KC, Wactawski-Wende J, Pan K, Anderson G; Breast Cancer Res. Treat.. 2015-12-01.
See more >>Medication use trajectories of postmenopausal breast cancer survivors and matched cancer-free controls.
Pan K, Chlebowski RT, Simon MS, Ray RM, Livaudais-Toman J, Sullivan SD, Stefanick ML, Wallace RB, LeBoff M, Bluhm EC, Paskett ED; Breast Cancer Res. Treat.. 2016-04-01.
See more >>Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer.
Chlebowski, R. T.,Pan, K.,Col, N. F.; Breast Cancer Res. Treat.. 2016 Oct 28.
See more >>